Miller Anestesia

1850 / 2894

131. Myburgh J, Cooper J, Finfer S, et al: Saline or
albumin for fluid resuscitation in patients with
traumatic brain injury. N Engl J Med 357:874–884,
2007.
132. Suarez JI, Shannon L, Zaidat OO, et al: Effect of
human albumin administration on clinical outcome
and hospital cost in patients with subarachnoid
hemorrhage. J Neurosurg 100:585–590, 2004.
133. Palesch YY, Hill MD, Ryckborst KJ, et al: The ALIAS
Pilot Trial: A dose-escalation and safety study of
albumin therapy for acute ischemic stroke. II: Neu-
rologic outcome and efficacy analysis. Stroke
37:2107–2114, 2006.
134. Ginsberg MD, Palesch YY, Hill MD: The ALIAS
(ALbumin In Acute Stroke) phase III randomized
multicentre clinical trial: Design and progress
report. Biochem Soc Trans 34:1323–1326, 2006.
135. Kozek-Langenecker SA: Effects of hydroxyethyl
starch solutions on hemostasis. Anesthesiology
103:654–660, 2005.
136. Cully MD, Larson CP, Silverberg GD: Hetastarch
coagulopathy in a neurosurgical patient [letter].
Anesthesiology 66:706–707, 1987.
137. Trumble ER, Muizelaar JP, Myseros JS, et al: Coagu-
lopathy with the use of hetastarch in the treatment
of vasospasm. J Neurosurg 82:44–47, 1995.
138. Kreimeier U, Messmer K: Small-volume resuscita-
tion: From experimental evidence to clinical
routine: Advantages and disadvantages of hyperto-
nic solutions. Acta Anaesthesiol Scand 46:625–638,
2002.
139. Cooper DJ, Myles PS, McDermott FT, et al: Prehos-
pital hypertonic saline resuscitation of patients with
hypotension and severe traumatic brain injury: A
randomized controlled trial. JAMA 291:1350–1357,
2004.
140. Qureshi AI, Suarez JI: Use of hypertonic saline
solutions in treatment of cerebral edema and intra-
cranial hypertension [review]. Crit Care Med
28:3301–3313, 2000.
141. Doyle JA, Davis DP, Hoyt DB: The use of hypertonic
saline in the treatment of traumatic brain injury.
J Trauma 50:367–383, 2001.
142. Horn P, Munch E, Vajkoczy P, et al: Hypertonic
saline solution for control of elevated intracranial
pressure in patients with exhausted response to
mannitol and barbiturates. Neurol Res 21:758–764,
1999.
143. Todd MM, Hindman BJ, Clarke WR, et al: Mild
intraoperative hypothermia during surgery for
intracranial aneurysm. N Engl J Med 352:135–145,
2005.
144. Crowder CM, Tempelhoff R, Theard A, et al: Jugular
bulb temperature: Comparison with brain surface
and core temperatures in neurosurgical patients
during mild hypothermia. J Neurosurg 85:98–103,
1996.
145. GrahamDI, Ford I, Adams JH, et al: Ischaemic brain
damage is still common in fatal non-missile head
injury. J Neurol Neurosurg Psychiatry 52:346–350,
1989.
146. Clifton GL, Jiang JY, Lyeth BG, et al: Marked pro-
tection by moderate hypothermia after experimen-
tal traumatic brain injury. J Cereb Blood Flow
Metab 11:114–121, 1991.
147. Marion DW, Obrist WD, Carlier PM, et al: The use
of moderate therapeutic hypothermia for patients
with severe head injuries: A preliminary report.
J Neurosurg 79:354–362, 1993.
148. Shiozaki T, Sugimoto H, Taneda M, et al: Effect of
mild hypothermia on uncontrollable intracranial
hypertension after severe head injury. J Neurosurg
79:363–368, 1993.
149. Clifton GL, Allen S, Barrodale P, et al: A phase II
study of moderate hypothermia in severe brain
injury. J Neurotrauma 10:263–273, 1993.
150. Metz C, Holzschuh M, Bein T, et al: Moderate
hypothermia in patients with severe head injury:
Cerebral and extracerebral effects. J Neurosurg
85:533–541, 1996.
151. Clifton GL, Miller ER, Choi SC, et al: Lack of effect
of induction of hypothermia after acute brain
injury. N Engl J Med 344:556–563, 2001.
152. Bernard SA, Gray TW, Buist MD, et al: Treatment
of comatose survivors of out-of-hospital cardiac
arrest with induced hypothermia. N Engl J Med
346:557–563, 2002.
153. Hypothermia After Cardiac Arrest Study Group:
Mild therapeutic hypothermia to improve the neu-
rologic outcome after cardiac arrest. N Engl J Med
346:549-556, 2002.
154. Nolan JP, Morley PT, Vanden Hoek TL, et al: Thera-
peutic hypothermia after cardiac arrest: an advisory
statement by the advanced life support task force of
the International Liaison Committee on Resuscita-
tion. Circulation 108:118–121, 2003.
155. Johansson B, Li CL, Olsson Y, et al: The effect of
acute arterial hypertension on the blood-brain
barrier to protein tracers. Acta Neuropathol (Berl)
16:117–124, 1970.
156. Forster A, Horn KV, Marshall LF, et al: Anesthetic
effects on blood-brain barrier function during acute
arterial hypertension. Anesthesiology 49:26–30,
1978.
157. Hatashita S, Hoff JT, Ishii S: Focal brain edema
associated with acute arterial hypertension. J Neu-
rosurg 64:643–649, 1986.
158. Mayhan WG: Disruption of blood-brain barrier
during acute hypertension in adult and aged rats.
Am J Physiol 258:H1735–H1738, 1990.
159. Kalfas IH, Little JR: Postoperative hemorrhage: A
survey of 4992 intracranial procedures. Neurosur-
gery 23:343–347, 1988.
160. Lewelt W, Hummel R, Littlewood K, et al: Recovery
from anesthesia and cerebral blood flow velocity
[abstract]. Anesth Analg 74:S186, 1992.
161. Bruder N, Pellissier D, Grillot P, et al: Cerebral hype-
remia during recovery from general anesthesia in
neurosurgical patients. Anesth Analg 94:650–654,
2002.
162. Grillo P, Bruder N, Auquier P, et al: Esmolol blunts
the cerebral blood flow velocity increase during
emergence from anesthesia in neurosurgical
patients. Anesth Analg 96:1145–1149, 2003.
163. Tanskanen PE, Kytta JV, Randell TT, et al: Dexme-
detomidine as an anaesthetic adjuvant in patients
undergoing intracranial tumour surgery: A double-
blind, randomized and placebo-controlled study. Br
J Anaesth 97:658–665, 2006.
164. Laidlaw JD, Siu KH: Poor-grade aneurysmal suba-
rachnoid hemorrhage: Outcome after treatment
with urgent surgery. Neurosurgery 53:1275–1282,
2003.
165. Broderick JP, Brott TG, Duldner JE, et al: Initial and
recurrent bleeding are the major causes of death
following subarachnoid hemorrhage. Stroke
25:1342–1347, 1994.
166. Amin-Hanjani S, Ogilvy CS, Barker FG II: Does
intracisternal thrombolysis prevent vasospasm after
aneurysmal subarachnoid hemorrhage? A meta-
analysis. Neurosurgery 54:326–334, 2004.
167. Dorai Z, Hynan LS, Kopitnik TA, et al: Factors
related to hydrocephalus after aneurysmal subara-
chnoid hemorrhage. Neurosurgery 52:763–771,
2003.
168. Tisdall M, Crocker M, Watkiss J, et al: Disturbances
of sodium in critically ill adult neurologic patients:
A clinical review. J Neurosurg Anesthesiol 18:57–63,
2006.
169. Wijdicks EFM, Vermeulen M, tenHaaf JA, et al:
Volume depletion and natriuresis in patients with a
ruptured intracranial aneurysm. Ann Neurol
18:211–216, 1985.
170. Okuchi K, Fujioka M, Fujiikawa A, et al: Rapid
natriuresis and preventive hypervolaemia for
symptomatic vasospasm after subarachnoid hae-
morrhage. Acta Neurochir 138:951–957, 1996.
171. Dumont AS, Kassell NF: Vasospasm. J Neurosurg
103:1–3, 2005.
172. Lin CL, Winardi W, Jeng AY, et al: Endothelin-con-
verting enzyme inhibitors for the treatment of
subarachnoid hemorrhage-induced vasospasm.
Neurol Res 28:721–729, 2006.
173. Vajkoczy P, Meyer B, Weidauer S, et al: Clazosentan
(AXV-034343), a selective endothelin A receptor
antagonist, in the prevention of cerebral vasospasm
following severe aneurysmal subarachnoid hemo-
rrhage: Results of a randomized, double-blind,
placebo-controlled, multicenter phase IIa study.
J Neurosurg 103:9–17, 2005.
174. Barth M, Capelle HH, Munch E, et al: Effects of the
selective endothelin A (ET(A)) receptor antagonist
Clazosentan on cerebral perfusion and cerebral
oxygenation following severe subarachnoid hemo-
rrhage—preliminary results from a randomized
clinical series. Acta Neurochir (Wien) 149:911–918,
2007.
175. HertelF,WalterC,BettagM
magnetic resonance imaging in patients with
vasospasm: A useful new tool in the management of
patients with subarachnoid hemorrhage. Neuro-
surgery 56:28–35, 2005.
176. Munch E, Vajkoczy P: Current advances in the
diagnosis of vasospasm. Neurol Res 28:703–712,
2006.
177. Weidauer S, Lanfermann H, Raabe A, et al: Impair-
ment of cerebral perfusion and infarct patterns
attributable to vasospasm after aneurysmal subara-
chnoid hemorrhage: A prospective MRI and DSA
study. Stroke 38:1831–1836, 2007.
178. Chang HS, Hongo K, Nakagawa H: Adverse effects
of limited hypotensive anesthesia on the outcome
of patients with subarachnoid hemorrhage. J Neu-
rosurg 92:971–975, 2000.
179. Foroohar M, Macdonald RL, Roth S, et al: Intraope-
rative variables and early outcome after aneurysm
surgery. Surg Neurol 54:304–315, 2000.
180. Treggiari MM, Walder B, Suter PM, et al: Systematic
review of the prevention of delayed ischemic neu-
rological deficits with hypertension, hypervolemia,
and hemodilution therapy following subarachnoid
hemorrhage. J Neurosurg 98:978–984, 2003.
181. Rinkel GJ, Feigin VL, Algra A, et al: Circulatory
volume expansion therapy for aneurysmal subara-
chnoid haemorrhage. Cochrane Database Syst Rev
CD000483, 2004.
182. Muizelaar JP, Becker DP: Induced hypertension for
the treatment of cerebral ischemia after subara-
chnoid hemorrhage. Surg Neurol 25:317–325,
1986.
183. Raabe A, Beck J, Keller M, et al: Relative importance
of hypertension compared with hypervolemia for
increasing cerebral oxygenation in patients with
cerebral vasospasm after subarachnoid hemorrhage.
J Neurosurg 103:974–981, 2005.
184. Kim DH, Joseph M, Ziadi S, et al: Increases in
cardiac output can reverse flow deficits from vasos-
pasm independent of blood pressure: A study using
xenon computed tomographic measurement of
cerebral blood flow. Neurosurgery 53:1044–1052,
2003.
185. Pickard JD, Murray GD, Illingworth R, et al: Effect
of oral nimodipine on cerebral infarction and
outcome after subarachnoid haemorrhage: British
aneurysm nimodipine trial. BMJ 298:636–642,
1989.
186. Petruk KC, West M, Mohr G, et al: Nimodipine
treatment in poor-grade aneurysm patients. J Neu-
rosurg 68:505–517, 1988.
187. Barker FG, Ogilivy CS: Efficacy of prophylactic
nimodipine for delayed ischemic deficit after suba-
rachnoid hemorrhage: Ameta-analysis. J Neurosurg
84:405–414, 1996.
188. Haley EC, Kassell NF, Torner JC, et al: A randomi-
zed controlled trial of high-dose intravenous nicar-
dipine in aneurysmal subarachnoid hemorrhage: A
report of the Cooperative Aneurysm Study. J Neu-
rosurg 78:537–547, 1993.
189. Haley EC, Kassell NF, Torner JC, et al: A randomi-
zed trial of nicardipine in subarachnoid hemo-
rrhage: Angiographic and transcranial Doppler
ultrasound results: A report of the Cooperative
Aneurysm Study. J Neurosurg 78:548–553, 1993.
190. Tseng MY, Czosnyka M, Richards H, et al: Effects of
acute treatment with pravastatin on cerebral vasos-
pasm, autoregulation, and delayed ischemic deficits
after aneurysmal subarachnoid hemorrhage: a
phase II randomized placebo-controlled trial.
Stroke 36:1627–1632, 2005.
1850 Anestesia por subespecialidades en el adulto IV